Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Peker, H. Glantz, J. Ejdebäck, A. Kallryd, J. Herlitz (Skövde, Skövde and Lidköping, Gothenburg, Sweden). Rationale and design of the randomised intervention with CPAP in coronary artery disease and obstructive sleep apnoea – RICCADSA trial. Eur Respir J 2007; 30: Suppl. 51, 3058

Member's Comments

No comment yet.

Related content which might interest you: CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Effect of CPAP treatment on adhesion molecules in coronary artery disease with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea Year: 2020 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Effects of exercise training on sleep apnoea in patients with coronary artery disease: a randomised trial Source: Eur Respir J 2016; 48: 142-150 Year: 2016 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017 Year: 2017 Late-breaking abstract: Cardiac function in a revascularized coronary artery disease cohort with obstructive sleep apnoea with and without daytime sleepiness in the RICCADSA trial Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults Year: 2011 Impact of a multimodal telemonitoring intervention on CPAP adherence in symptomatic low-cardiovascular risk sleep apnea: a randomized controlled trial Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea Year: 2020 Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013 Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019 Year: 2019 Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Late Breaking Abstract: Baseline characteristics of the revascularized patients with coronary artery disease and obstructive sleep apnoea in the RICCADSA trial Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010 Effect of obstructive sleep apnoea on cardiovascular outcomes in patients with acute coronary syndrome: a secondary analysis of the RICCADSA trial Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 Web-based follow-up of CPAP compliance in obstructive sleep apnea syndrome: A pilot study Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea Year: 2011 Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018 Year: 2018